These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 5829164)
1. The clinical comparison between tubocurarine and diallylnortoxiferine in children. Bush GH Br J Anaesth; 1965 Jul; 37(7):540-3. PubMed ID: 5829164 [No Abstract] [Full Text] [Related]
2. [2 years of exclusive use of diallyl-nor-toxiferine as relaxant in clinical anesthesia]. Chott F Anaesthesist; 1966 Mar; 15(3):81-3. PubMed ID: 5987377 [No Abstract] [Full Text] [Related]
3. [The role of diallyl-nor-toxiferin in the group of relaxants]. Ahnefeld FW; Halmágyi M Anaesthesist; 1966 Mar; 15(3):83-5. PubMed ID: 5987378 [No Abstract] [Full Text] [Related]
4. A comparative study between diallylnortoxiferine and tubocurarine. Baraka A Br J Anaesth; 1967 Aug; 39(8):624-8. PubMed ID: 6035130 [No Abstract] [Full Text] [Related]
6. Comparison of diallyl-nor-toxiferine and d-tubocurarine in humans. Influence of the induction agent. Stovner J; Endresen R; Lund I Bull Schweiz Akad Med Wiss; 1967 Aug; 23(1):91-7. PubMed ID: 4860568 [No Abstract] [Full Text] [Related]
7. The effect of alcuronium and tubocurarine on blood pressure and heart rate: a clinical comparison. Tammisto T; Welling I Br J Anaesth; 1969 Apr; 41(4):317-22. PubMed ID: 5780736 [No Abstract] [Full Text] [Related]
8. The clinical use of muscle relaxants. Foldes FF Bull Schweiz Akad Med Wiss; 1967 Aug; 23(1):5-24. PubMed ID: 6049585 [No Abstract] [Full Text] [Related]
9. [Research on ocular hypotonia caused by alloferine during general anesthesia]. Tota G; Vagelli A; Busoni P Ann Ottalmol Clin Ocul; 1967 Feb; 93(2):171-9. PubMed ID: 5601344 [No Abstract] [Full Text] [Related]
11. [Modes of acton of muscle relaxants]. Yoshino M Masui; 1972 Apr; 21(4):321-35. PubMed ID: 4261711 [No Abstract] [Full Text] [Related]
12. Neuromuscular effects of d-tubocurarine, edrophonium and neostigmine in man. Katz RL Anesthesiology; 1967; 28(2):327-36. PubMed ID: 6026052 [No Abstract] [Full Text] [Related]
13. [Influence of antibiotic treatment on the course of anesthesia. (Experimental research)]. Samele Acquaviva E; Bajardi A Acta Anaesthesiol; 1968; 19(4):599-610. PubMed ID: 5755774 [No Abstract] [Full Text] [Related]
14. The influence of carbon dioxide on the neuromuscular blocking properties of tubocurarine chloride and diallyl-nor-toxiferine dichloride (Alloferin Roche) in man. A comparative study. Coleman AJ; Ripley SH; Sliom CM; Knowles SL Bull Schweiz Akad Med Wiss; 1967 Aug; 23(1):98-105. PubMed ID: 4860569 [No Abstract] [Full Text] [Related]
15. Clinical experiences with diallyl-nor-toxiferine and the curare antidote galanthamine. Mayrhofer O South Med J; 1966 Nov; 59(11):1364-8. PubMed ID: 5333582 [No Abstract] [Full Text] [Related]
16. Sensitivity to dimethyltubocurarine and toxiferine with special reference to serum proteins. Stovner J; Theodorsen L; Bjelke E Br J Anaesth; 1972 Apr; 44(4):374-80. PubMed ID: 5032074 [No Abstract] [Full Text] [Related]
17. THE CLINICAL COMPARISON BETWEEN D-TUBOCURARINE AND DIALLYLNORTOXIFERINE IN CHILDREN. BUSH GH Proc R Soc Med; 1965 Aug; 58(8):633. PubMed ID: 14341852 [No Abstract] [Full Text] [Related]
18. [On the problem of muscle relaxants]. Benad G Z Arztl Fortbild (Jena); 1966 Jan; 60(2):99-102. PubMed ID: 5983561 [No Abstract] [Full Text] [Related]
19. Quantitative assessment of residual antidepolarizing block. II. Ali HH; Utting JE; Gray TC Br J Anaesth; 1971 May; 43(5):478-85. PubMed ID: 4254032 [No Abstract] [Full Text] [Related]
20. The choice and mode of administration of relaxants. Foldes FF Clin Anesth; 1966; 2():1-32. PubMed ID: 5958093 [No Abstract] [Full Text] [Related] [Next] [New Search]